Tenet Reports Results for the Second Quarter Ended June 30, 2016

Go back to Tenet Reports Results for the Second Quarter Ended June 30, 2016

Mizuho Securities Cuts Price Target on Tenet Healthcare (THC) to $28; Reiterates Neutral

August 2, 2016 8:11 AM EDT

Mizuho Securities maintained a Neutral rating on Tenet Healthcare (NYSE: THC), and cut the price target to $28.00 (from $33.00), following the company's 2Q earnings report.

Analyst Sheryl Skolnick commented, "The Mama issue is not a 'once and done, now it's behind them' thing. It's... More

Tenet Healthcare (THC) Misses Q2 EPS by 14c, Offers FY16 & Q3 Guidance

August 1, 2016 5:18 PM EDT

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $0.38, $0.14 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $4.87 billion versus the consensus estimate of $4.83 billion.

GUIDANCE:

Tenet Healthcare sees FY2016 EPS of $1.32-$1.67, versus the consensus of $1.93.... More